Photo taken from FDA Oncology/X
Apr 28, 2024, 16:36
FDA Oncology: OCE’s Project Facilitate processed 401 calls and 889 applications for oncology investigational drugs
FDA Oncology shared a post on X:
“In 2023, OCE’s Project Facilitate handled 401 phone calls and 889 Expanded Access applications for oncology investigational drugs. Learn more in the OCE Annual Report.”
Source: FDA Oncology/X
The Oncology Center of Excellence (OCE) was given authorization through the 21st Century Cures Act of 2016 and formally founded on January 19, 2017. This Center brings together specialists from across the FDA to facilitate accelerated evaluations of medical products intended for the treatment of oncologic and hematologic malignancies. The OCE also leads numerous initiatives aimed at advancing both the research and regulatory processes related to medical products for individuals affected by cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59
Nov 13, 2024, 10:54
Nov 13, 2024, 10:45